CN Patent

CN102421426A — 肠胃外给药的对乙酰氨基酚

Assigned to Fresenius Kabi Deutschland GmbH · Expires 2012-04-18 · 14y expired

What this patent protects

本发明涉及一种含水药物组合物，优选输注液，用于肠胃外给药，其含有对乙酰氨基酚并且具有最高为200μS cm -1 的导电性。

USPTO Abstract

本发明涉及一种含水药物组合物，优选输注液，用于肠胃外给药，其含有对乙酰氨基酚并且具有最高为200μS cm -1 的导电性。

Drugs covered by this patent

Patent Metadata

Patent number
CN102421426A
Jurisdiction
CN
Classification
—
Expires
2012-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Fresenius Kabi Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.